GM Bacteria in Vaginal Microflora Will Protect Against HIV

Californian biotech company Osel told about the progress in the development of a new approach to AIDS, based on the use of natural protective properties of vaginal microflora. Researchers have succeeded in obtaining GM lactobacillus line secreting antibody fragments that are capable of neutralizing the human immunodeficiency virus (HIV) at the stage of penetration into the body. The authors report bbout these AIDS Research and Human Retroviruses magazines.

Newly Discovered Key Components of HIV Can Lead to More Effective Drugs

Work on the genetic modification of Lactobacillus jensenii, typical representatives of the vaginal microflora, has been going on for more than 12 years. Earlier, the head of the research department of the company Osel, Laurel Lagenaur and his colleagues have reported receiving GM-lines capable of producing tsianovirin-N, antiviral protein. Bacteria have been successfully tested on monkeys, that shown reducing transmission of the virus by 63%. Now, however, the authors presented a new line of lactobacillus that produce antibodies in the mucous agaisnt viral protein GP120, which is more specific.

GP120 protein is one of the most important in the HIV shell: it binds to the CD4-receptors on the surface of T-lymphocytes and ensures their infection. This makes GP120 an attractive target for the action of drugs against HIV. In particular, it recognized by small artificially constructed single domain antibodies m9, m36 and m36.4, genes that scientists have introduced into the strain Lactobacillus jensenii-1153.

Most viruses enters a body through mucosal surfaces, and for women the mucous membranes of the vagina and cervix - is the most important gateway for HIV - explains Laurel Legenaur. Lactobacillus vaginal microflora already play a protective role, weakening the inflammatory processes that facilitate HIV entry. Genetic modification of these bacteria will provide antiviral antibodies in place of invasion.

Developers of the company Osel will implement these principles in MucoCept concept, which should be crowned with a wide medical use of GM lactobacillius which can prevent the penetration of HIV into a body. According to company management, for the moment the technology is still in its development stage, but in two years it will be brought to the stage of clinical trials.

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Cart Preview

Men Who Can Do 40 Push-Ups Have Lower Risk of Heart Disease

Men Who Can Do 40 Push-Ups Have Lower Risk of Heart Disease

A new study from the US suggests that middle-aged men who are able to do 40 push-ups and more in one session have lower risk of cardiovascular disease than men who can do fewer than 10 push-ups. For a retrospective longitudinal study from 2000 to 2010, 1,104...

Getting Enough Sleep at Night Can Reduce the Risk of Heart Disease

Getting Enough Sleep at Night Can Reduce the Risk of Heart Disease

Recent research from Massachusetts General Hospital in Boston, US, suggests that getting enough sleep at nights connected to the decreased risk of developing atherosclerosis, a condition in which plaque builds up on the inner walls of the arteries. For the study, a...

[WpProQuiz 1]

Featured Products

Kangoo Jumps Training: 5 Beginner Exercises

In childhood, many of us dreamed of learning to jump high. Now, after years, it became easier - Kangoo Jumps has appeared. This is one of the relatively new, but quickly gaining popularity types of fitness training. There are several advantages of jumpers. ...

read more
All original content on these pages is fingerprinted and certified by Digiprove